Levels of Tumor Markers and Associated Factors in Type 2 Diabetes Mellitus
Bin JIANG,Shan-mei SHEN,Lu JIN,Tian TIAN,Meng SUN,Yan BI,Da-long ZHU
DOI: https://doi.org/10.3969/j.issn.1007-9572.2017.11.002
2017-01-01
Chinese General Practice
Abstract:Objective To investigate the levels of serum tumor markers and associated factors in type 2 diabetes mellitus (T2DM).Methods Two hundred and eight patients with T2DM who received inpatient treatment in Department of Endocrinology,Nanjing Pukou Hospital of TCM,and Department of Endocrinology,Nanjing Drum Tower Hospital,the Affiliated Hospital of Nanjing University Medical School,were selected as the participants of study.The serum albumin,glycosylated hemoglobin (HbA1c),triglyceride (TG),total cholesterol (TC),low-density lipoprotein cholesterol (LDL-C),high-density lipoprotein cholesterol (HDL-C) and serum tumor markers,such as CA125,CA199,alpha fetoprotein (AFP),carcino-embryonic antigen (CEA),CA72-4,CA153,CA242,CA50,CYFRA21-1,neuron-specific enolase (NSE) and serum ferritin (SF) levels were detected.In the steamed bun meal tolerance test,the levels of fasting plasma glucose (FPG),2 h postprandial plasma glucose (2 hPG),fasting insulin (FINS),2 h postprandial insulin (2 hINS),fasting C-peptide (FC-P),2 h postprandial C-peptide (2 hC-P) were detected.Results Among the 208 patients,there were 6 cases of abnormal CA125 (2.9％),30 cases of abnormal CA199 (14.7％),2 cases of abnormal AFP (1.0％),5 cases of abnormal CEA (2.5％),23 cases of abnormal CA72-4 (11.6％),5 cases of abnormal CA153 (2.5％),17 cases of abnormal CA242 (8.5％),6 cases of abnormal CA50 (3.0％),15 cases of abnormal CYFRA21-1 (7.5％),12 cases of abnormal NSE (6.0％) and 11 cases of abnormal SF (5.4％).The levels of CEA,CA153 and CYFRA21-1 were higher in patients aged ＞60 years old than in those aged ≤60 years old (P ＜0.05);patients with the course of T2DM ＞ 10 years had higher levels of CEA and CA153 but lower SF levels than those with the course of T2DM ≤ 10 years (P ＜0.05);the levels of CA199,CEA,CA242,CA50 and SF were higher in patients with HbA1c ＞ 7.0％ than in those with HbA1c ≤7.0％ (P ＜ 0.05);there were statistically significant differences in the levels of CA199,CA72-4,CA242,CA50 and SF among T2DM patients with FPG ＜ 7.0,7.0-10.0 and ＞ 10.0 mmol/L (P ＜ 0.05);the level of CA199 in patients with HOMA-IR ＞ 8.90 was higher than that in those with HOMA-IR ≤ 8.90 (P ＜ 0.05);there were statistically significant differences in the levels of CA199 and SF among patients with HOMA-HBCI ＜ 20.25,20.25-35.93,35.94-83.03 and ＞83.03 (P ＜0.05).Multivariate linear regressions analysis showed that the medication history of INS [β =-16.275,95％ CI (-33.729,-1.179)],HbA1c [β=3.495,95％CI (1.663,8.653)],HDL-C [β=-48.374,95％CI (-85.373,-11.374)],HOMA-IR [β=1.107,95％CI (0.309,1.906)] and HOMA-HBCI [β=-0.419,95％CI (-0.955,-0.194)] were associated factors of CA199 levels in T2DM patients (P ＜ 0.05).Conclusion The abnormally increased levels of a variety of tumor markers,found in T2DM patients,are related to the FPG levels under control,insulin resistance and islet cell function.Insulin resistance and poor blood glucose control are the risk factors of the increased CA199 level,while high HDL-C and islet cell function are its protective factors.